Explorative Clinical Study on the Performance and Acceptance of New Intermittent Catheters in Healthy Volunteers
Explorative Clinical Study Investigating the Performance and Acceptance of New Intermittent Catheters in Healthy Volunteers
1 other identifier
interventional
9
1 country
1
Brief Summary
Performance and acceptance of new intermittent catheters tested in healthy volunteers
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2018
CompletedFirst Submitted
Initial submission to the registry
May 28, 2019
CompletedFirst Posted
Study publicly available on registry
January 18, 2020
CompletedResults Posted
Study results publicly available
March 24, 2025
CompletedMarch 24, 2025
March 1, 2025
2 months
May 28, 2019
January 29, 2020
March 5, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Urine Flow Rate
On day of study visits 1-5 rate of urine flow through catheter measured in mL/s
2 hour
Secondary Outcomes (2)
Post-void Residual Urine
2 hour
Number of Participants With Hematuria
2 hour
Study Arms (3)
Test product 2
EXPERIMENTALTest catheter 2
Test product 3
EXPERIMENTALTest catheter 3
Comparator
ACTIVE COMPARATORSpeediCath Flex
Interventions
Eligibility Criteria
You may qualify if:
- Has given written informed consent and signed letter of authority Is at least 18 years of age and has full legal capacity Is a male Willing to comply without using analgetica up to 24 hours prior to catheterisation visits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Coloplast A/Slead
Study Sites (1)
Coloplast A/S
Humlebæk, 3050, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Medical Affairs Vice President
- Organization
- Coloplast A/S
Study Officials
- PRINCIPAL INVESTIGATOR
Birte Jakobsen, MD
Coloplast A/S
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2019
First Posted
January 18, 2020
Study Start
November 5, 2018
Primary Completion
December 20, 2018
Study Completion
December 20, 2018
Last Updated
March 24, 2025
Results First Posted
March 24, 2025
Record last verified: 2025-03